Medical/Pharmaceuticals
Alps Pharmaceutical confirms through human pharmacokinetic studies that its newly developed natural quercetin formulation can significantly reduce quercetin usage
HIDA, Japan, Aug. 1, 2022 /PRNewswire/ -- On Aug 02, 2022, with the recent surge in raw material prices and the continued scarcity of quercetin in the market, Alps Pharmaceutical Ind. Co., Ltd. (Hida,Japan, President: Osamu Ushimaru) announced that it has confirmed through human pharmacokinetic s...
2022-08-01 12:28
1445
Active Motif Incorporated Licenses Targeted Transposition to Diagenode S.A. Technology
CARLSBAD, Calif., Aug. 1, 2022 /PRNewswire/ -- Active Motif Incorporated, a company with the vision of bringing epigenetics more deeply into precision medicine, announced that it has non-exclusively licensed its foundational patents in transposition for use in CUT&Tag epigenetic assays to Diageno...
2022-08-01 11:30
1669
CHEMICAL INDUSTRIES (FAR EAST) LIMITED MARKS 60TH ANNIVERSARY WITH $60,000 DONATION TO SOULJOURN
SINGAPORE, Aug. 1, 2022 /PRNewswire/ -- Founded in 1962, Chemical Industries (Far East) Limited (CIL) commemorated its 60th anniversary with a dinner for employees, customers and business partners at The Capitol Kempinski Hotel on 29 th July 2022. As part of its commemoration, CIL made a $60,000 d...
2022-08-01 10:40
2659
PERSISTENT LOSS OF SMELL DUE TO COVID-19 CLOSELY CONNECTED TO LONG-LASTING COGNITIVE PROBLEMS
FROM THE ALZHEIMER'S ASSOCIATION INTERNATIONAL CONFERENCE 2022 Also, ICU Stay May Double Risk of Dementia in Older Adults SAN DIEGO, Aug. 1, 2022 /PRNewswire/ -- New insights into factors that may predict, increase or protect against the impact of COVID-19 and the pandemic on memory and thinkin...
2022-08-01 09:03
2081
Innovent and Laekna Jointly Announce First Patient Dosed with Three-drug Combination in a Phase 1/2 Study for the Treatment of Patients with Solid Tumors Who Were Resistant to Prior Anti-PD-1/PD-L1 Therapy
SAN FRANCISCO and SUZHOU, China, Aug. 1, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and ot...
2022-08-01 08:00
2321
LIMES Randomised Controlled Trial about Sirolimus Coated Balloon in BTK takes the first Stride: patient enrolment started
Concept Medical Inc.
2022-07-29 20:56
4840
EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany
Collaboration aims to drive innovation and nurture talent that could help power sustainable business growth for the company HONG KONG, July 29, 2022 /PRNewswire/ -- EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", HKEX: 1846) an...
2022-07-29 20:14
1848
HanAll Biopharma Reports Second Quarter 2022 Results and Provides Business Update
* Financial performance for Q2 2022 records revenues of KRW 26.2 billion, a 12% growth from the same period last year, driven by strong sales performance from the pharmaceutical division * Operating income turned to profit compared to the last quarter, while investment to R&D continued in t...
2022-07-29 20:00
2779
Seegene unveils strategies for global expansion at 2022 AACC
Company has taken part in the Annual Scientific Meeting & Clinical Lab Expo since 2007 This year's event showcased its In-life PCR campaign and STARlet-AIOS Seegene also displayed Novaplex™ assays, including a test for detecting the monkeypox virus SEOUL, South Korea, July 29, 2022 /PRNewswire/...
2022-07-29 19:00
2827
HistoIndex Stain-free AI-DP Reveals Treatment-induced Zonal Regression of Fibrosis Colocalized with Reduction in Steatosis & Hepatocyte Ballooning in FLIGHT-FXR NASH Clinical Trial
SINGAPORE, July 29, 2022 /PRNewswire/ -- HistoIndex, a global leading artificial intelligence digital pathology (AI-DP) provider, announced that its AI-based qFibrosis®, qSteatosis® and qBallooning® algorithms delivered sensitivity and granularity on a greater scale, as compared with the current ...
2022-07-29 19:00
1859
EuroEyes signs tri-party agreement of mutual cooperation with leading medical universities in the PRC and Germany
Collaboration aims to drive innovation and nurture talent that could help power sustainable business growth for the company Hong Kong, July 29, 2022 /PRNewswire/ -- EuroEyes International Eye Clinic Limited ("EuroEyes" or the "Company", together with its subsidiaries, the "Group", HKEX: 1846) an...
2022-07-29 18:43
3180
As part of 'Operation Nasal Vaccine' to counter COVID-19 spread, ACM-001 booster vaccine administered to first subject in phase 1 safety and immunogenicity trial
SINGAPORE and BASEL, Switzerland and SYDNEY, July 29, 2022 /PRNewswire/ -- ACM
Biolabs
2022-07-29 16:00
2058
ZAODX World Conference on Early Detection of Cancer was successfully held in Guangzhou, China
GUANGZHOU, China, July 29, 2022 /PRNewswire/ -- The inaugural ZAODX World Conference on Early Detection of Cancer ("the Conference") was successfully held at the Chimelong International Conference Center inGuangzhou from July 15-17, 2022. In attendance were founders and representatives from over ...
2022-07-29 15:35
1382
MAYNE PHARMA AND GOODRX ANNOUNCE NEW INITIATIVE TO INCREASE AWARENESS OF NEXTSTELLIS® AND EXPAND ACCESS TO BIRTH CONTROL
* Mayne Pharma enters into strategic agreement with GoodRx * GoodRx and Mayne Pharma to collaborate and deliver an enhanced NEXTSTELLIS® direct-to-consumer (DTC) program ADELAIDE, Australia, July 29, 2022 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) is pleased to announce a new strat...
2022-07-29 13:00
1432
QT MEDICAL'S Online Order, Mail Delivery, XPRESS ECG Testing Service, to Exhibit at the World's Largest Annual Trade Show
Enabling patients to conduct electrocardiogram (ECG) tests safely and efficiently at home using PCA 500, the only medical grade 12-lead Resting ECG approved by the FDA for patient use. LAS VEGAS, July 29, 2022 /PRNewswire/ -- Demand for telehealth and home care has surged drastically during the ...
2022-07-29 12:22
1518
Taiwan Startup PrecisemAb Continues Progress Towards Vision of Safest Antibody Treatment With No Side Effects
The Universal Antibody Lock technology will give patients more of a choice
TAIPEI, July 29, 2022 /PRNewswire/ -- PrecisemAb Biotech
2022-07-29 12:09
1345
Lynk Pharmaceuticals Announces the First Participant Dosed in Phase I Trial of LNK01004
HANGZHOU, China, July 29, 2022 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. (hereinafter referred to as 'Lynk Pharmaceuticals'), an innovative clinical stage company, announced that it has completed dosing the first participant in the phase I clinical study inChina for its self-developed, in...
2022-07-29 10:00
3210
Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target
The Science Based Targets initiative has validated Illumina's targets to reach Net-Zero greenhouse gas emissions by 2050 SINGAPORE, July 29, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first g...
2022-07-29 09:24
3439
Lenstec SBL-3 multifocal intraocular lens for cataract surgery approved by FDA for sale in the US
Lenstec Inc. has announced that its SBL-3 IOL has been approved by the FDA. ST. PETERSBURG, Fla., July 29, 2022 /PRNewswire/ -- The Lenstec SBL-3 IOL (Segmented Bifocal Lens) is a next-generation asymmetric multifocal refractive IOL which provides patients with near, intermediate and distance vis...
2022-07-29 05:43
1992
Daewoong Pharmaceutical Co., Ltd. revs up the growth engine for Nabota, achieving the highest quarterly performance ever
- Daewoong Pharmaceutical Co., Ltd. achieved 293.8 billion won in sales and 33.6 billion won in operating revenue in the second quarter due to the growth of ethical drugs and Nabota. - A continuous increase in profitability is expected due to sales visualization of the new drug Fexuclue and Na...
2022-07-28 21:00
1970
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00
Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 291 media titles]
2024-04-30 10:11
Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39
Chinese new energy industry contributes to global green, low-carbon transition
[Picked up by 249 media titles]
2024-04-30 15:13New International Land-Sea Trade Corridor achieves rapid development
[Picked up by 246 media titles]
2024-04-28 10:24Most Read
Scienjoy Holding Corporation Reports Fiscal Year 2023 Financial Results
2024-04-27 04:30
2931
